Are electronic signatures legally valid?

Yes. In the United States electronic signatures meet the legal test when they demonstrate signer intent, consent to transact electronically, attribution, and retention per ESIGN (15 U.S.C. ch. 96) and UETA where adopted; exceptions for wills and certain court filings remain.

What authentication level is required?

Authentication should match risk: email-only may suffice for low-risk documentation, while regulated clinical records often require stronger methods such as MFA, identity proofing, or PKI-based signatures. Align authentication choices with sponsor policy, audit expectations, and 21 CFR Part 11 considerations.

Can consent forms be signed remotely?

Yes if state and institutional requirements are met. Use documented consent process, validated platforms, identity verification, and recording when required. Check state-specific rules and IRB policy; for some jurisdictions or vulnerable populations additional in-person verification may be required.

How long must audit logs be retained?

Retention depends on document type and applicable law. Federal guidance often mandates at least the study lifecycle plus several years; HIPAA requires six years for PHI (45 CFR §164.530(j)). Sponsors should follow regulatory requirements and sponsor-specific policies.

What formats are acceptable for submission?

Use regulator-preferred, machine-readable formats where specified. PDFs are standard for signed records; datasets should follow CDISC standards (e.g., SDTM, ADaM) when required. Preserve native export files and include metadata and checksums to support validation and reproducibility.

Does ESIGN apply to clinical records?

Yes. The ESIGN Act (15 U.S.C. ch. 96) establishes legal equivalence for electronic signatures in interstate commerce. UETA governs intrastate transactions in most states. Verify exceptions such as wills, certain court filings, and other statutorily excluded documents.

Electronic Signature
Templates
Healthcare
Good Clinical Data Management Practices Draft Guidance

Good Clinical Data Management Practices Draft Guidance

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

What the Draft Guidance Covers

The Good Clinical Data Management Practices Draft Guidance provides recommended standards and procedural expectations for collecting, processing, quality-assuring, and preserving clinical trial data used to support regulatory submissions. It addresses data collection methods, case report form design, data validation rules, discrepancy management, source data verification, audit trails, and metadata requirements. The draft guidance is intended to align sponsors, clinical data managers, and contract research organizations with U.S. regulatory expectations for data integrity and traceability throughout the study lifecycle, including requirements for electronic systems and records.

Why Following the Guidance Matters

Adhering to the Good Clinical Data Management Practices Draft Guidance improves data quality, reduces regulatory risk, and supports reliable analysis for safety and efficacy decisions. It clarifies expectations for electronic records and audit trails consistent with ESIGN and UETA principles for admissible electronic evidence.

Who Typically Uses This Guidance

Typical users include sponsors, CROs, clinical data managers, biostatisticians, and regulatory affairs professionals responsible for trial data integrity.

Sponsors overseeing trial design, data submission packages, and regulatory interactions.
Contract Research Organizations executing data entry, validation, and data transfer functions.
Clinical data managers and biostatisticians implementing cleaning, reconciliation, and database lock processes.

Step-by-Step: Aligning Study Data Practices

Follow these core steps to align study data collection and processing with the draft guidance.

01

Plan: Define data standards, CRF structure, and metadata needs before study start.
02

Collect: Use validated EDC or source systems with timestamped entries and access controls.
03

Validate: Implement edit checks, reconciliation rules, and discrepancy workflows.
04

Preserve: Maintain audit trails, backups, and exportable records for regulatory review.

Core Sections to Expect in the Draft Guidance

Core sections in the draft guidance outline data lifecycle, validation, metadata standards, security controls, system validation, and submission-ready exports requirements.

Data Lifecycle

Defines stages from collection through archival, including responsibilities, timing for source verification, rules for derived variables, and expected formats for datasets submitted to regulators (CDISC or equivalent).

CRF Design

Guidance on CRF layout, standard controlled vocabularies, mandatory fields, skip logic, and versioning controls to ensure consistent data capture across sites and EDC systems sponsors.

Validation

Specifies automated edit checks, cross-form reconciliation, source data verification sampling plans, and procedures for documenting and resolving discrepancies with audit trail entries and sign-off records.

System Controls

Describes role-based access, segregation of duties, system configuration control, backup schedules, and password and session management to protect data integrity and availability encryption in transit and at rest.

Audit Trail

Requires tamper-evident audit logs capturing user actions, timestamps, IP addresses, field-level changes, and retention policies sufficient for regulatory inspection and reconstruction with exportable reports on demand.

Submission Exports

Specifies formats, dataset structure, metadata mapping, and validation checks for regulator-ready exports, including study metadata and reproducible derivation logic for analysis datasets and a manifest of datasets and checksums.

Required Data Elements and System Metadata

Patient Identifier: Unique subject code linking to source records.

Event Timestamp: MM/DD/YYYY HH:MM in system timezone.

Operator ID: Name and role of data entry user.

Audit Trail: Immutable log with action, time, and actor.

CRF Version: Version identifier and effective date.

Source Reference: Link to original medical record or lab output.

Typical Electronic Workflow Configuration

Typical electronic workflow settings map fields, validation rules, routing, and archival behavior to study requirements.

Field	Configuration
Authentication method and required verifier strength	Email OTP, SMS code, or KBA per risk
Field validation rules and error messaging	Edit checks, range checks, mandatory flags, custom messages
Routing, signer order, and escalation steps	Sequential signers, conditional routing, and notification windows
Archive retention and export configuration settings	Automated exports, retention schedule, checksum generation, and backups

How Electronic Signing and Export Work in Practice

Simplified routing shows sender setup through signer actions to final export for regulatory review and archival.

Upload: Upload the master protocol and CRFs in PDF or DOCX.
Tag Fields: Place signature, initial, date, and data fields on pages.
Send: Notify signers by email or provide secure signing link.
Export: Generate submission-ready exports with audit trail and checksums.

Platform Capabilities Needed for Compliance

Electronic submissions require platform features that preserve integrity, authentication, and retrievability for audits and support export in regulator-preferred formats.

File formats: PDF, DOCX, XML, and CSV supported.
Integrations: Common: Salesforce, NetSuite, Microsoft 365, Box.
Security: TLS 1.2/1.3 in transit; AES-256 at rest.

Platforms should support configurable authentication methods, detailed immutable audit logs, role-based access controls, encryption in transit and at rest, exportable compliance reports, and the ability to execute a Business Associate Agreement (BAA) for HIPAA-covered workflows.

Key Timing and Deadline Considerations

Key timing considerations include documentation dates, retention start points, and regulatory submission windows for clinical datasets.

Primary data capture date field:

Record in MM/DD/YYYY format at point of entry.

Database lock and submission schedule:

Set target relative to last patient last visit and analysis plan.

Audit trail retention policy and duration:

Keep full audit trails per retention schedule and inspections.

Issue resolution and query timelines:

Define SLA for query resolution, typically 7–30 calendar days.

Regulatory submission and dataset delivery window:

Coordinate timing with regulatory filing plans and any pre-specified lock dates.

Common Mistakes to Avoid

Incomplete metadata or inconsistent variable naming across sites causes mismatches during aggregation and can delay regulatory review and analysis timelines.
Failing to document source data provenance, export timestamps, and checksums undermines the reproducibility of derived datasets and raises audit findings.
Relying on manual reconciliation without automated edit checks increases transcription errors and increases time required to achieve database lock.
Applying inadequate user authentication or weak session controls can permit unauthorized changes and compromise the integrity of clinical data.

Consequences of Noncompliance

Regulatory Findings: FDA inspection observations under 21 CFR Part 11.

Data Rejection: Submission datasets could be rejected.

Legal Exposure: Compromised data may lead to enforcement.

Financial Risk: Delayed approvals increase study costs.

Scientific Integrity: Erroneous data undermines conclusions.

Operational Delay: Rework extends timelines and resource use.

Frequently Asked Questions and Practical Answers

Common questions about applying the draft guidance, e-signatures, and system controls are answered below to reduce compliance uncertainty.

Need help? Contact support

Are electronic signatures legally valid?
Yes. In the United States electronic signatures meet the legal test when they demonstrate signer intent, consent to transact electronically, attribution, and retention per ESIGN (15 U.S.C. ch. 96) and UETA where adopted; exceptions for wills and certain court filings remain.
What authentication level is required?
Authentication should match risk: email-only may suffice for low-risk documentation, while regulated clinical records often require stronger methods such as MFA, identity proofing, or PKI-based signatures. Align authentication choices with sponsor policy, audit expectations, and 21 CFR Part 11 considerations.
Can consent forms be signed remotely?
Yes if state and institutional requirements are met. Use documented consent process, validated platforms, identity verification, and recording when required. Check state-specific rules and IRB policy; for some jurisdictions or vulnerable populations additional in-person verification may be required.
How long must audit logs be retained?
Retention depends on document type and applicable law. Federal guidance often mandates at least the study lifecycle plus several years; HIPAA requires six years for PHI (45 CFR §164.530(j)). Sponsors should follow regulatory requirements and sponsor-specific policies.
What formats are acceptable for submission?
Use regulator-preferred, machine-readable formats where specified. PDFs are standard for signed records; datasets should follow CDISC standards (e.g., SDTM, ADaM) when required. Preserve native export files and include metadata and checksums to support validation and reproducibility.
Does ESIGN apply to clinical records?
Yes. The ESIGN Act (15 U.S.C. ch. 96) establishes legal equivalence for electronic signatures in interstate commerce. UETA governs intrastate transactions in most states. Verify exceptions such as wills, certain court filings, and other statutorily excluded documents.

Explore Templates

Request to Renew Restraining Order California Living Trust Amendment to Living Trust Revocation Trust Form Restraining Order California Proof of Service

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now